Polymorphisms in CTLA-4 have been associated with several autoimmune diseases, including systemic lupus erythematosus and insulin-dependent diabetes mellitus; a general susceptibility to autoimmune diseases has also been described for CTLA-4 polymorphisms [37-39], emphasizing its pivotal role in immune tolerance. This evidence concerns the gene CTLA4 and type 1 diabetes mellitus.